# HOXA6

## Overview
HOXA6 is a gene that belongs to the homeobox (HOX) gene family, which is known for encoding transcription factors that play pivotal roles in developmental processes. The protein encoded by HOXA6, homeobox A6, functions as a transcription factor characterized by a 60-amino acid homeodomain that facilitates DNA binding. This protein is integral to the regulation of gene expression, particularly in the context of hemopoietic cell proliferation and differentiation. HOXA6 is involved in maintaining the balance between cell proliferation and differentiation, which is crucial for normal development and cellular function. Alterations in the expression or function of HOXA6 have been linked to various cancers, where it may act as either an oncogene or a tumor suppressor, depending on the context (Xiulin2022Nextgeneration; Wu2019HOXA6; Dickson2009Hoxa6).

## Structure
HOXA6 is a member of the homeobox gene family, which encodes transcription factors with a characteristic 60-amino acid homeodomain responsible for DNA binding. The primary structure of HOXA6 includes this homeodomain, which is crucial for its function as a transcription factor. The secondary structure of the homeodomain typically involves alpha helices, which facilitate the binding to DNA.

Post-translational modifications of HOXA6 may include phosphorylation, which can influence the protein's activity, stability, and interaction with other molecules. These modifications are essential for regulating the function of the protein in various cellular processes.

HOXA6 can also undergo alternative splicing, resulting in different isoforms. These splice variants may have distinct functions or regulatory roles within the cell, contributing to the complexity of gene regulation and expression. The presence of multiple isoforms allows for a diverse range of functional capabilities, which can be crucial for the precise control of developmental processes and cellular differentiation.

## Function
HOXA6 is a member of the HOX gene family, which encodes transcription factors that play a crucial role in regulating gene expression during development. In healthy human cells, HOXA6 is involved in hemopoietic cell proliferation and self-renewal. It is expressed in hemopoietic progenitor cells, with higher expression in more primitive cells and decreasing as cells become more lineage-committed (Dickson2009Hoxa6). HOXA6 potentiates short-term hemopoietic cell proliferation and extended self-renewal, suggesting its role in maintaining and expanding the hemopoietic cell population (Dickson2009Hoxa6).

HOXA6 is also implicated in the regulation of cell cycle dynamics, as its overexpression leads to increased proliferation rates and altered cell cycle phases, with more cells in the G0/G1 or G2/M phases (Dickson2009Hoxa6). This gene is part of the HOXA cluster, which is crucial for establishing definitive hematopoietic stem cell fate, indicating its involvement in the endothelial-to-hematopoietic transition (Dou2016Medial). The expression of HOXA6 in normal tissues, as opposed to its downregulation in certain cancers, suggests a role in maintaining normal cellular functions and preventing uncontrolled cell growth (Wu2019HOXA6).

## Clinical Significance
HOXA6 has been implicated in several cancers due to its altered expression and genetic mutations. In low-grade glioma (LGG) and glioblastoma multiforme (GBM), HOXA6 is significantly up-regulated compared to normal samples. This up-regulation is associated with poor clinical outcomes, including shorter overall survival, disease-specific survival, and progression-free survival in LGG patients. HOXA6 expression, along with tumor grade, age, and primary therapy outcome, are independent prognostic factors in LGG. Genetic alterations such as missense mutations and copy number variations (CNVs) in HOXA6 are common in LGG and correlate with its expression levels, impacting survival outcomes. HOXA6 also plays a role in immune regulation and inflammation response, suggesting potential as a target for immunotherapy (Xiulin2022Nextgeneration).

In clear cell renal cell carcinoma (ccRCC), HOXA6 is downregulated, and its overexpression leads to decreased cell proliferation and increased apoptosis. This effect is mediated by the suppression of the PI3K/Akt signaling pathway, indicating that HOXA6 acts as a tumor suppressor in ccRCC (Wu2019HOXA6).

In colorectal cancer (CRC), HOXA6 is frequently hypermethylated, leading to its silencing. This hypermethylation is associated with early tumor stages and may serve as a biomarker for early diagnosis and prognosis (Li2019Study).

## Interactions



## References


[1. (Li2019Study) Daojiang Li, Yang Bai, Zhicai Feng, Wanwan Li, Chunxing Yang, Yihang Guo, Changwei Lin, Yi Zhang, Quanyong He, Gui Hu, and Xiaorong Li. Study of promoter methylation patterns of hoxa2, hoxa5, and hoxa6 and its clinicopathological characteristics in colorectal cancer. Frontiers in Oncology, May 2019. URL: http://dx.doi.org/10.3389/fonc.2019.00394, doi:10.3389/fonc.2019.00394. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2019.00394)

[2. (Dou2016Medial) Diana R. Dou, Vincenzo Calvanese, Maria I. Sierra, Andrew T. Nguyen, Arazin Minasian, Pamela Saarikoski, Rajkumar Sasidharan, Christina M. Ramirez, Jerome A. Zack, Gay M. Crooks, Zoran Galic, and Hanna K. A. Mikkola. Medial hoxa genes demarcate haematopoietic stem cell fate during human development. Nature Cell Biology, 18(6):595–606, May 2016. URL: http://dx.doi.org/10.1038/ncb3354, doi:10.1038/ncb3354. This article has 83 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncb3354)

[3. (Xiulin2022Nextgeneration) Jiang Xiulin, Chunyan Wang, Jishu Guo, Chenyang Wang, Chenglong Pan, and Zhi Nie. Next-generation sequencing identifies hoxa6 as a novel oncogenic gene in low grade glioma. Aging, 14(6):2819–2854, March 2022. URL: http://dx.doi.org/10.18632/aging.203977, doi:10.18632/aging.203977. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.18632/aging.203977)

[4. (Wu2019HOXA6) Feixiang Wu, Shasha Wu, Hang Tong, Weiyang He, and Xin Gou. Hoxa6 inhibits cell proliferation and induces apoptosis by suppressing the pi3k/akt signaling pathway in clear cell renal cell carcinoma. International Journal of Oncology, April 2019. URL: http://dx.doi.org/10.3892/ijo.2019.4789, doi:10.3892/ijo.2019.4789. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.2019.4789)

[5. (Dickson2009Hoxa6) Glenda J. Dickson, Alexandra Kwasniewska, Ken I. Mills, Terence R.J. Lappin, and Alexander Thompson. Hoxa6 potentiates short-term hemopoietic cell proliferation and extended self-renewal. Experimental Hematology, 37(3):322-333.e3, March 2009. URL: http://dx.doi.org/10.1016/j.exphem.2008.10.015, doi:10.1016/j.exphem.2008.10.015. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.exphem.2008.10.015)